New US Policy On SEP Remedies Restores Critical Balance
In January 2013, the U.S. Department of Justice's Antitrust Division and the U.S. Patent and Trademark Office issued a joint policy statement that has generally been interpreted to limit the availability...To view the full article, register now.
Already a subscriber? Click here to view full article